Dear Molecular Imaging Insider,
What are the best strategies to use when performing PET/CT for lung disease? If you're not sure, you might want to read this week's Insider Exclusive.
Researchers from the U.S. and the U.K. worked together to produce a consensus statement on the optimal PET parameters to use. Their advice ranges from patient preparation to image reconstruction to how to overcome obstacles like respiratory motion effects.
As a Molecular Imaging Insider, you get access to this Insider Exclusive article by Contributing Editor Wayne Forrest before the rest of the AuntMinnie.com membership.
In related news, researchers from Japan discussed PET/CT's prowess for detecting recurrence of disease in non-small cell lung cancer patients after they've undergone surgery. The results indicate that molecular imaging could be a useful tool for tracking patients after treatment.
And in the realm of PET/MRI, researchers from Germany used the hybrid modality to stage patients scheduled for cancer treatment, finding that it detected 25% more cancers than PET/CT. PET/MRI could be especially well-suited for pediatric patients due to its lower radiation burden.
Other important stories that have appeared in the Molecular Imaging Community over the past few weeks include the following:
- PET could help diagnose idiopathic normal pressure hydrocephalus, a form of dementia that's amenable to surgical treatment.
- An experimental PET radiopharmaceutical shows promise for imaging inflammation in the lungs.
- The U.S. National Institutes of Health is funding a research study to examine the use of PET to study Alzheimer's disease among Mexican Americans.
- PET with the radiolabeled amino acid F-18 fluoroethyl tyrosine can help assess the efficacy of radiotherapy in some cancer patients who develop brain metastases.
These are just a few of the many articles on molecular imaging that you'll find in the community. Check out the headlines below for the rest of the news in this exciting discipline.
